Early and advanced stages of cancer can be detected with a simple blood test, which can detect proteins and/or other substances made by the cancer in your blood. Give our Integrative Cancer Specialists a call to learn more.
Content coming soon
Since most cancers take 8-10 years to develop into a tumor that can be detected by traditional means, the EDS Bio Survey (cancer profile) is a critical aspect of determining where in the cancer cascade your body currently is. The cancer cascade is how cancer works and the steps you can take to either return your body to health or prevent your body from being a good “host” for cancer to develop. If your body tests positive for needing one of the Natura formulas, then you can extrapolate that there is a weakened system and the right environment for cancer to continue to grow undetected by the immune system. With this early energetic positive testing, a nutritional protocol can then be created that can reverse the cascade before a tumor even develops. Remember, the tumor is just a symptom of the cancer’s overgrowth for many years.
The Natura line of Chinese formulas are targeted and system specific for each organ system. Used as drugs for treatment of cancer for over a hundred years in China, they were brought to the U.S. over 12 years ago by AmericanNutriceuticals’ founder Bill Coury and have been used successfully by hundreds of practitioners as part of a full nutritional and therapeutic protocol.
The Natura formula would be the base of the protocol with other supplements given to support your body and change your “good host” status.
Here at Cancer Center For Healing we offer you personalized cancer care by testing your genetics through R.G.C.C.-USA, LLC’s blood analysis test. This blood test analyzes circulating tumor cells and cancer stem cells through targeted test results. Cancer Center For Hope is then able to tailor cancer treatment plans for our patients to enhance treatment outcomes. R.G.C.C. analysis has revolutionized how we care for our cancer patients. Over the past nine years, more than 300 physicians worldwide have utilized the R.G.C.C. personalized cancer care analysis with their patients and have seen tremendous strides in cancer survival.
The R.G.C.C. tests are designed to assess which types of cancer treatments will be most effective for a specific person and type of cancer.
ONCOCOUNT: This test will report only the number of Circulating Cancer Tumor Cells (CTC’s). It does not include any other information concerning the CTC’s or Circulating Cancer Stem Cells (CSC’s).
ONCOTRACE: This test will report the number of CTC’s, any positive CSC’s, and the immunophenotype of these cells. The most useful screening test. This test should be ordered first and if positive one can then order the TU Profile Plus. R.G.C.C. must be notified by e-mail to continue with the TU Plus Profile before the 9th day after receiving results. If one waits longer a new blood sample will be needed.
ONCOTRAIL: This test is a tailor made test for a specific type of malignancy such as breast cancer (Oncotrail for Breast), prostate (Oncotrail for Prostate) and so on. This test includes only markers relative to a specific type of malignancy which makes the test for follow up control patient management.
TU PROFILE: This includes the chemosensitivity/chemoresistance assessment for cytotoxic drugs, monoclonal antibodies, and small molecules that inhibit specific targets eg. (TKI, etc.). No natural substances tested.
TU PROFILE PLUS: This test is the TU PROFILE TEST, above, and includes the assessment of natural substances and plant extracts for any anticancer potency. The most complete and the most information for personal cancer care and support.
TU PROFILE EXTRACTS: This test includes only the assessment of natural substances and plant extracts for any anticancer potency. No chemotherapeutic agents tested and no tumor suppressor genes tested.
SUPPORTIVE OLIGONUCLEOTIDE TECHNIQUE (SOT): This is not a test, rather the patient’s blood is used to make the SOT by using the mRNA to induce certain gene expressions. SOT has the ability to induce apoptosis in the CTCs and all primary and metastatic tumors. The SOT can also be used for viruses.
Thermography advocates have long supported a collaborative approach. The American College of Clinical Thermography describes thermography as “an adjunct to the appropriate use of mammography,” not a competitor. The ACCT website states, “thermography has the ability to identify patients at the highest risk and actually increase the effective usage of mammographic imaging procedures.” Thermography has the ability to pick up thermal findings, changes in the skin that are due to early breast cancer, that can be found years before it’s visible on a mammogram. Women under age 50 have denser breast tissue, which makes it more difficult for mammograms to detect abnormalities. Breast cancers are particularly aggressive and grow significantly faster in younger women.
Call (949) 581-HOPE (4673), email us at email@example.com , or chat with us live to schedule your appointment. We are here to answer any questions and to help you schedule a personal consultation with an Integrative Cancer Specialist.